{"disease":{"id":"cerebral-palsy-mixed","name":"cerebral palsy mixed"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03744884","title":"Movement Characterization in Spastic/Dystonic Cerebral Palsy Using Haptic Feedback in Virtual Reality","phase":"NA","overall_status":"UNKNOWN","enrollment_count":68,"lead_sponsor_name":"University of Illinois at Urbana-Champaign","has_results":false},{"nct_id":"NCT03668548","title":"10-week Leucine Supplementation in Cerebral Palsy","phase":"NA","overall_status":"UNKNOWN","enrollment_count":25,"lead_sponsor_name":"St Mary's University College","has_results":false},{"nct_id":"NCT06307561","title":"The Effect of Dystonia Severity on Participation in Daily Living Activities and Caregivers in Children of Cerebral Palsy With Secondary Dystonia","phase":"","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Acıbadem Atunizade Hospital","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}